MARKET

ABT

ABT

Abbott Labs
NYSE
98.34
+0.05
+0.05%
Opening 14:19 09/30 EDT
OPEN
98.63
PREV CLOSE
98.29
HIGH
99.50
LOW
97.89
VOLUME
2.50M
TURNOVER
98.45M
52 WEEK HIGH
142.60
52 WEEK LOW
97.55
MARKET CAP
172.21B
P/E (TTM)
20.44
1D
5D
1M
3M
1Y
5Y
FDA Says Continuing, Under Conditions, To Exercise Enforcement Discretion On Importation, Sale In Domestic Commerce Of Certain Baby Formula Products; FDA
FDA Published Guidance To Help Provide A Pathway For Infant Formulas Operating Under Enforcement Discretion In The U.S. To Remain On The Market -Reuters
Benzinga · 5h ago
Here's Why Abbott Laboratories (NYSE:ABT) Has Caught The Eye Of Investors
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Simply Wall St. · 1d ago
Going Beyond Disaster Relief To Disaster Resilience
NORTHAMPTON, MA / ACCESSWIRE / September 28, 2022 / Abbott Resilience. It's often defined as the ability to recover quickly from challenges and difficulties. It requires adaptability and is a skill that is especially important for families and communities ...
ACCESSWIRE · 1d ago
Abbott Hosts Conference Call for Third-Quarter Earnings
Abbott (NYSE: ABT) will announce its third-quarter 2022 financial results on Wednesday, Oct. 19, 2022, before the market opens.
PR Newswire · 2d ago
Bubs Australia inks JV deal to produce infant formula products in China
Bubs Australia inks JV deal to produce infant formula products in China
Reuters · 2d ago
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Benzinga · 3d ago
FDA updates COVID-19 test policy to cut emergency use requests
Revising its COVID-19 test policy, the U.S. Food and Drug Administration (FDA) said Tuesday that the agency would review only a small number of new emergency use authorization (EUA) requests for diagnostic tests.Instead, the FDA urges deve...
Seekingalpha · 3d ago
Abbott (ABT) Stock Moves -0.83%: What You Should Know
In the latest trading session, Abbott (ABT) closed at $99.84, marking a -0.83% move from the previous day.
Zacks · 3d ago
More
About ABT
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Webull offers kinds of Abbott Laboratories stock information, including NYSE:ABT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABT stock methods without spending real money on the virtual paper trading platform.